Binge DrinkingAlcoolPredictNCT02794311
Risk Factors Associated With Binge Drinking Behaviors Among College Students
A study testing Alcoolpredict in people with Binge Drinking, run by CHU de Reims at 1 site in France.
Trial summary
The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts. Read more about this study
- Who is it for?
- Ages 18 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Binge Drinking
- What is being tested?
- Alcoolpredict
- How many people
- 125 participants
- Where
- 1 siteFrance
- Study dates
- Feb 2015to 24 Sep 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Males or females
- Right-handed
- Aged 18-25 years
- Native French speaker, able to read French and complete study evaluations
- Caucasian
- Able to provide informed written and verbal consent
Who cannot join
- A significant general medical illness, including neurological disorders, mental retardation or head trauma
- Depression, bipolar disorder, schizophrenia or schizoaffective disorder diagnostic according to DSM-IV
- Handling of psychotropics substances
- A sensorial impairment (visual and/or hearing)
- Women who are pregnant
- Contraindication to the use of MRI (pacemaker, metal in their body)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: AlcoholPredict: Neuropsychology, Brain Imaging and Genetic Polymorphisms in Binge Drinking
The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.
Read the detailed description
Binge drinking behavior is characterised by speed of drinking on a particular occasion, frequency of drunkenness during the most recent six month period, and the percentage of times getting drunk when drinking. The prevalence of weekly binge drinking among European Union drinkers in 2009 was reported to be 28% of the student population, and 33% among all young people aged 15-24. The consequences of this behavior are multiple and often dramatic, they include: academic failure, violent acts, rape, domestic or road accidents. The study aims to identify vulnerability factors associated with binge drinking. The protocol explores the psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) patterns associated with binge drinking behavior.
- Conditions
- Binge Drinking
- Being tested
- Alcoolpredict
- Medical subject headings
- Binge Drinking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AlcoolpredictOther
psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI)
What is being measured
The primary outcome is the main question the study is designed to answer.
Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I)
Measured: day 1
Neuropsychological test : Wisconsin Card Sorting Test (WCST)
Measured: V2(3 weeks later)
Genetics tests (Single Nucleotide Polymorphism)
Measured: V2(3 weeks later)
MRI - signal BOLD (" Blood Oxygen Level Dependant ").
Measured: V3(up to 2 month)
Neuropsychological test : Family Informant Schedule and Criteria (FISC)
Measured: day 1
Neuropsychological test : Alcohol Use Questionnaire
Measured: day 1
Neuropsychological test :Trail Making Test, partie A et B
Measured: V3(up to 2 month)
Neuropsychological test : Plus/Minus Test
Measured: V3(up to 2 month)
Neuropsychological test :Go/No-Go
Measured: V3(up to 2 month)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jun 2016 (estimated)
- Study startFeb 2015
- Primary completion24 Sep 2019
- Study completion24 Sep 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Binge DrinkingStudies of the same condition, open and under way.
- More trials run by CHU de ReimsThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 125 participants (actual)
Sponsor and investigators
- Lead sponsor
- CHU de Reims
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02794311
- Sponsor's protocol ID
- PO13129
- Acronym
- AlcoolPredict
- Status last verified
- Jun 2020
- First submitted
- 12 May 2016
- Last updated
- 21 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Lannoy S, Dricot L, Benzerouk F, Portefaix C, Barriere S, Quaglino V, Naassila M, Kaladjian A, Gierski F. Neural Responses to the Implicit Processing of Emotional Facial Expressions in Binge Drinking. Alcohol Alcohol. 2021 Feb 24;56(2):166-174. doi: 10.1093/alcalc/agaa093.
PubMed 33075804
Study at a glance
From the registry record, last updated by the sponsor on 21 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- AlcoholPredict: Neuropsychology, Brain Imaging and Genetic Polymorphisms in Binge Drinking
- ClinicalTrials.gov ID
- NCT02794311
- Acronym / sponsor ID
- AlcoolPredict / PO13129
- Conditions
- Binge Drinking
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 125 participants (actual)
- Lead sponsor
- CHU de ReimsUniversity, hospital or other
- Study start
- Feb 2015
- Primary completion
- 24 Sep 2019 (actual)
- Study completion
- 24 Sep 2019 (actual)
- First posted
- 9 Jun 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.
Detailed description
Binge drinking behavior is characterised by speed of drinking on a particular occasion, frequency of drunkenness during the most recent six month period, and the percentage of times getting drunk when drinking. The prevalence of weekly binge drinking among European Union drinkers in 2009 was reported to be 28% of the student population, and 33% among all young people aged 15-24. The consequences of this behavior are multiple and often dramatic, they include: academic failure, violent acts, rape, domestic or road accidents. The study aims to identify vulnerability factors associated with binge drinking. The protocol explores the psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) patterns associated with binge drinking behavior.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Males or females
- Right-handed
- Aged 18-25 years
- Native French speaker, able to read French and complete study evaluations
- Caucasian
Key exclusion criteria (6 listed)
- A significant general medical illness, including neurological disorders, mental retardation or head trauma
- Depression, bipolar disorder, schizophrenia or schizoaffective disorder diagnostic according to DSM-IV
- Handling of psychotropics substances
- A sensorial impairment (visual and/or hearing)
- Women who are pregnant
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Alcoolpredictpsychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) | Other | – |
Primary outcome
Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I)
Time frame: day 1
Neuropsychological test : Wisconsin Card Sorting Test (WCST)
Time frame: V2(3 weeks later)
Genetics tests (Single Nucleotide Polymorphism)
Time frame: V2(3 weeks later)
MRI - signal BOLD (" Blood Oxygen Level Dependant ").
Time frame: V3(up to 2 month)
Neuropsychological test : Family Informant Schedule and Criteria (FISC)
Time frame: day 1
Neuropsychological test : Alcohol Use Questionnaire
Time frame: day 1
Neuropsychological test :Trail Making Test, partie A et B
Time frame: V3(up to 2 month)
Neuropsychological test : Plus/Minus Test
Time frame: V3(up to 2 month)
Neuropsychological test :Go/No-Go
Time frame: V3(up to 2 month)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jan 2026.
- Results publication: PubMed 33075804Lannoy S, Dricot L, Benzerouk F, Portefaix C, Barriere S, Quaglino V, Naassila M, Kaladjian A, Gierski F. Neural Responses to the Implicit Processing of Emotional Facial Expressions in Binge Drinking. Alcohol Alcohol. 2021 Feb 24;56(2):166-174. doi: 10.1093/alcalc/agaa093.
Related trials for Binge Drinking
Recruiting
Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers
Drinking, Binge
Recruiting
Understanding the Associations Between Romantic Relationship Conflict, Psychophysiological Responding and Alcohol Misuse Among Emerging Adults
Heavy Episodic Drinking
Recruiting
Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults
Binge Alcohol Consumption, Suicidal Ideation
Recruiting
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
Alcohol Drinking, Heavy Drinking
Recruiting
Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use
Alcohol Drinking, Binge Drinking
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Alcoolpredict in people with Binge Drinking, run by CHU de Reims at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I) (time frame: day 1). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02794311, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jan 2026.